The store will not work correctly when cookies are disabled.
(E)-3-oxo-1,3-dihydroisobenzofuran-5-yl-(4-nitro)cinnamate
ID: ALA4557755
PubChem CID: 155554831
Max Phase: Preclinical
Molecular Formula: C17H11NO6
Molecular Weight: 325.28
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(/C=C/c1ccc([N+](=O)[O-])cc1)Oc1ccc2c(c1)C(=O)OC2
Standard InChI: InChI=1S/C17H11NO6/c19-16(8-3-11-1-5-13(6-2-11)18(21)22)24-14-7-4-12-10-23-17(20)15(12)9-14/h1-9H,10H2/b8-3+
Standard InChI Key: IJXFGVHHWBRVQT-FPYGCLRLSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
34.1679 -3.2811 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1668 -4.1006 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8748 -4.5096 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8730 -2.8722 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.5816 -3.2775 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.5819 -4.0961 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.3606 -4.3489 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8416 -3.6864 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
36.3601 -3.0244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.6124 -2.2471 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.4601 -2.8727 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.7525 -3.2814 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0447 -2.8730 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7527 -4.0986 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.3371 -3.2818 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6293 -2.8734 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6329 -2.0559 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9260 -1.6476 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2174 -2.0564 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2202 -2.8778 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9277 -3.2824 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5080 -1.6520 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.8009 -2.0617 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.5067 -0.8349 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 5 1 0
9 10 2 0
1 11 1 0
11 12 1 0
12 13 1 0
12 14 2 0
13 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
22 23 2 0
22 24 1 0
19 22 1 0
M CHG 2 22 1 24 -1
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 325.28 | Molecular Weight (Monoisotopic): 325.0586 | AlogP: 2.88 | #Rotatable Bonds: 4 |
Polar Surface Area: 95.74 | Molecular Species: NEUTRAL | HBA: 6 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.70 | CX Basic pKa: ┄ | CX LogP: 3.67 | CX LogD: 3.67 |
Aromatic Rings: 2 | Heavy Atoms: 24 | QED Weighted: 0.28 | Np Likeness Score: -0.08 |
References
1. Rodrigues MP, Tomaz DC, Ângelo de Souza L, Onofre TS, Aquiles de Menezes W, Almeida-Silva J, Suarez-Fontes AM, Rogéria de Almeida M, Manoel da Silva A, Bressan GC, Vannier-Santos MA, Rangel Fietto JL, Teixeira RR.. (2019) Synthesis of cinnamic acid derivatives and leishmanicidal activity against Leishmania braziliensis., 183 [PMID:31542714] [10.1016/j.ejmech.2019.111688] |